IOMED INC
10-K, EX-27.1, 2000-09-28
PHARMACEUTICAL PREPARATIONS
Previous: IOMED INC, 10-K, EX-23.1, 2000-09-28
Next: HELLER FUNDING CORP, 8-K, 2000-09-28



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE IOMED,
INC. CONDENSED CONSOLIDATED BALANCE SHEETS AND STATEMENTS OF OPERATIONS FOR THE
TWELVE MONTHS ENDED JUNE 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                      15,097,000
<SECURITIES>                                         0
<RECEIVABLES>                                1,417,000
<ALLOWANCES>                                    78,000
<INVENTORY>                                    767,000
<CURRENT-ASSETS>                            17,322,000
<PP&E>                                       3,803,000
<DEPRECIATION>                               2,895,000
<TOTAL-ASSETS>                              19,916,000
<CURRENT-LIABILITIES>                        1,617,000
<BONDS>                                        586,000
                                0
                                  6,881,000
<COMMON>                                    34,490,000
<OTHER-SE>                                (23,658,000)
<TOTAL-LIABILITY-AND-EQUITY>                19,916,000
<SALES>                                     10,596,000
<TOTAL-REVENUES>                            10,767,000
<CGS>                                        3,692,000
<TOTAL-COSTS>                               12,882,000
<OTHER-EXPENSES>                             (986,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              26,000
<INCOME-PRETAX>                            (1,155,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,155,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,155,000)
<EPS-BASIC>                                   (0.18)
<EPS-DILUTED>                                   (0.18)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission